- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging drugs in the treatment of pancreatic cancer
Authors
Keywords
-
Journal
EXPERT OPINION ON EMERGING DRUGS
Volume 14, Issue 2, Pages 311-328
Publisher
Informa Healthcare
Online
2009-05-26
DOI
10.1517/14728210902972502
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase I study with the agonistic TRAIL-R1 antibody, mapatumumab, in combination with gemcitabine and cisplatin
- (2017) C. Oldenhuis et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase IB study of AMG 479, a type 1 insulin-like growth factor receptor (IGF1R) antibody, in combination with panitumumab (P) or gemcitabine (G)
- (2017) J. Sarantopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201
- (2017) P. J. Loehrer et al. JOURNAL OF CLINICAL ONCOLOGY
- New directions in the management of advanced pancreatic cancer: a review
- (2010) Caio M. Rocha-Lima ANTI-CANCER DRUGS
- HIF-1α and STAT3 client proteins interacting with the cancer chaperone Hsp90: Therapeutic considerations
- (2010) Hanna Leah Kim et al. CANCER BIOLOGY & THERAPY
- Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study
- (2008) B. Chauffert et al. ANNALS OF ONCOLOGY
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Gemcitabine Combined with Gefitinib in Patients with Inoperable or Metastatic Pancreatic Cancer: A Phase II Study of the Hellenic Cooperative Oncology Group with Biomarker Evaluation
- (2008) George Fountzilas et al. CANCER INVESTIGATION
- The role of hypoxia-inducible factors in tumorigenesis
- (2008) E B Rankin et al. CELL DEATH AND DIFFERENTIATION
- STAT3 as a target for inducing apoptosis in solid and hematological tumors
- (2008) Khandaker Al Zaid Siddiquee et al. CELL RESEARCH
- Molecular Approaches towards the Inhibition of the Signal Transducer and Activator of Transcription 3 (Stat3) Protein
- (2008) Steven Fletcher et al. ChemMedChem
- Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis
- (2008) Christian Moser et al. EUROPEAN JOURNAL OF CANCER
- Reovirus therapy in cancer: has the orphan virus found a home?
- (2008) Timothy A Yap et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Deforolimus (AP23573) a novel mTOR inhibitor in clinical development
- (2008) Monica Mita et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Challenges in developing targeted therapy for pancreatic adenocarcinoma
- (2008) Devalingam Mahalingam et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma
- (2008) William F. Regine et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prediagnostic Plasma Folate and the Risk of Death in Patients With Colorectal Cancer
- (2008) Brian M. Wolpin et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy in Addition to Supportive Care Improves Survival in Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 16 Randomized Controlled Trials
- (2008) JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Douglas B. Evans et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers
- (2008) Alex A. Adjei et al. JOURNAL OF CLINICAL ONCOLOGY
- Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trials
- (2008) J. Rodon et al. MOLECULAR CANCER THERAPEUTICS
- Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer
- (2008) Dongweon Song et al. MOLECULAR CANCER THERAPEUTICS
- Insulin-like growth factor-I receptor blockade by a specific tyrosine kinase inhibitor for human gastrointestinal carcinomas
- (2008) Wenhua Piao et al. MOLECULAR CANCER THERAPEUTICS
- An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer
- (2008) G. Feldmann et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More